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Abstract: Nitric oxide (NO) modulates diverse
functions of polymorphonuclear neutrophils (PMNs),
but localization of NO synthase (NOS) and identi-
fication of its interacting proteins remain the least
defined. The present study discerns subcellular dis-
tribution of NOS and caveolin-1, a prominent
NOS-interacting protein in rat PMNs. Localization
of NOS was explored by confocal and immunogold
electron microscopy, and its activity was assessed
by L-[3H] arginine and 4,5-diaminofluorescein di-
acetate (DAF-2DA). Reverse transcriptase-poly-
merase chain reaction using NOS primers and
Western blotting demonstrated the presence of
neuronal NOS (nNOS) and inducible NOS (iNOS)
in PMNs. Immunocytochemical studies exhibited
distribution of nNOS and iNOS in cytoplasm and
nucleus, and L-[3H] citrulline formation and DAF
fluorescence confirmed NOS activity in both frac-
tions. NOS activity correlated positively with cal-
modulin concentration in both of the fractions.
nNOS and iNOS colocalized with caveolin-1, as
evidenced by immunocytochemical and immuno-
precipitation studies. The results thus provide first
evidence of nNOS and iNOS in the nuclear com-
partment and suggest NOS interaction with caveo-
lin-1 in rat PMNs. J. Leukoc. Biol. 79: 519–528;
2006.
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INTRODUCTION
Nitric oxide (NO) regulates several important functions of
polymorphonuclear neutrophils (PMNs), including chemotaxis,
adhesion, aggregation, apoptosis, and PMN-mediated bacterial
killing or tissue damage [1]. The presence of NO synthase
(NOS) in the primary granules of PMNs has implied a pivotal
cytotoxic role of NO in combating pathogens [2]. Several stud-
ies from our laboratory have also demonstrated NO-mediated
modulation of free radical generation from PMNs in various
physiological and pathological conditions [3–8].
Although the presence of NO in the subcellular compart-
ments can be of significance in modulating diverse targets, only
one study is available about the localization of NOS in intra-
cellular locations by immunohistochemistry [2]. Inducible NOS
(iNOS) and constitutive NOS activity and immunoreactivity
were associated with various subcellular compartments as well
as with the nucleus of endothelial cells [9], brown adipocytes
[10], and astrocytes [11]. A recent report about the nuclear
localization of biopterin (BH4) biosynthesizing enzymes,
guanosine 5-triphosphate cyclohydrolase I, 6-pyruvoyl-tetra-
hydropterin synthase, and sepiapterin reductase is of consid-
erable relevance to the availability of a redox-sensitive cofactor
to support NO synthesis in the nuclear compartment [12].
Although biochemical and molecular characteristics of NOS
are well explored [5, 13, 14], there is no report available about
NOS localization in rat PMNs. Although only neuronal NOS
(nNOS) is constitutively expressed in rat PMNs, induction of
iNOS has been documented within 2 h after lipopolysaccharide
(LPS) treatment [14]. Several splice variants of nNOS have
been reported: nNOS, a full-length protein has a PSD-95/
discs large/ZO-1 homology (PDZ) domain, and nNOS and
nNOS lack this domain [15]. Primers used by Greenberg et al.
[14] did not verify the presence of PDZ domain in nNOS being
expressed in rat PMNs.
Sequestration of NOS in intracellular compartments is a
result of various interacting proteins [16], which modulate its
enzymatic activity [17–19], spatial distribution [20], proximity
with regulators [21, 22], and intended targets [23]. Caveolin-1,
a prominent NOS-interactive protein, negatively modulates
endothelial NOS (eNOS), nNOS, and iNOS by interfering with
calmodulin (CaM) binding [24–26]. The present study was
undertaken to investigate the hitherto unexplored subcellular
localization of NOS isoforms and caveolin-1 in the rat-circu-
lating PMNs.
MATERIALS AND METHODS
Reagents and antibodies
L-[3H] Arginine and goat anti-mouse and goat anti-rabbit protein A gold were
from Amersham Pharmacia Biotech (Uppsala, Sweden). Uranyl acetate was
from Polaron Equipment Ltd. (Watford, UK). Monoclonal antibodies (mAb) to
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nNOS (N-2280) and iNOS (N-9657) and all other chemicals were from Sigma-
Aldrich Co. (St. Louis, MO).
Rabbit polyclonal antibodies against caveolin-1 (N-20: sc-894), iNOS
(M-19: sc-650G), nNOS (K-20: sc-1025), and horseradish peroxidase goat
anti-rabbit/donkey anti-goat were from Santa Cruz Biotechnology (CA). Goat
anti-rabbit Oregon Green 488 (OG 488) and anti-mouse indocarbocyanin-5
(Cy5) were from Molecular Probes (Eugene, OR). mAb to rat CD11b-fluores-
cein isothiocyanate and CD45-phycoerythrin were from BD Biosciences (San
Diego, CA).
Animals
Male Sprague-Dawley rats (200–250 g) were obtained from the institute animal
house. The animals were kept in a conventional housing facility and were used
in accordance with institutional ethical guidelines.
Neutrophil isolation
PMNs were isolated using the method of Yazdanbakhsh et al. [27] with
modifications. Buffy coat diluted with phosphate-buffered saline (PBS) con-
taining tri sodium citrate 15 mM, 0.5% (w/v) bovine serum albumin (BSA), and
glucose 10 mM was loaded over 1 ml Histopaque-1077 and centrifuged (1000
g at 25C) for 20 min. Original density of cells was restored by suspending
cells in rat plasma containing 5% (v/v) fetal calf serum for 30 min. PMNs were
separated over Histopaque-1083 and -1119 gradients, washed with PBS,
counted, and suspended in Hanks’ balanced salt solution [HBSS; composition
(mM): NaCl 138, KCl 2.7, Na2HPO4 8.1, KH2PO4 1.5, glucose 10, pH
7.2–7.4]. PMNs purity was90% as assessed by CD11b/CD45; contaminating
cells in the PMN suspension were mostly lymphocytes.
Isolation of nuclei from PMNs and their
morphological characterization
PMNs were fractionated according to Sanghavi et al. [28]. Briefly, cells
(1108cells/ml) were suspended in lysis buffer [composition (mM): HEPES
10, NaCl 10, MgCl2 1.5, EDTA 1, dithiothreitol 5, 10% glycerol, and 0.15%
Nonidet P-40 (NP-40), pH 7.4]. After brief vortexing and centrifugation (1700
g at 4°C for 5 min), supernatant cytoplasmic fraction (CF) was collected.
Nuclei fraction (NF) pellet was washed with lysis buffer (without NP-40) and
finally suspended in HBSS (equal to CF). Purity of NF was assessed by DNA
content [29] and lactate dehydrogenase (LDH) activity [3]. Purity of NF and the
morphological characterization of PMNs in buffy coat were identified under
transmission electron microscopy (TEM; FEI Philips Tecnai-12). Buffy coat
and isolated nuclei were fixed overnight at 25°C with 2% (w/v) paraformalde-
hyde and 1% (v/v) glutaraldehyde in PBS (pH 7.4). Fixed nuclei impregnated
in 4% buffered agarose were cut into smaller pieces using razor blades, washed
thoroughly with PBS, post-fixed in buffered 1% osmium tetroxide for 3 h,
dehydrated in ascending series of ethanol, and finally, embedded in Epon and
Araldite plastic resin [30]. Ultrathin sections (80–100 nm) cut by Ultra Cut
ultramicrotome (Leica, Austria) were contrasted with uranyl acetate and lead
citrate and examined under TEM at 80 kV.
Assessment of NOS activity
4,5-Diaminofluorescein diacetate (DAF-2DA) fluorescence
Cells (107/ml) were washed with HBSS, preincubated with NOS inhibitor
3-bromo 7-nitroindazole (7-NI; 1 mM), NOS substrate L-arginine (1 mM), or
vehicle for 30 min at 37°C, and subsequently, incubated with DAF-2DA (10
M) for 5 min. DAF-loaded PMNs were dispensed on 0.01% (w/v) poly-L-
lysine-coated coverslips, and NO production was visualized [31] using BioRad
Radiance 2100 laser-scanning system equipped with a Nikon Eclipse TE 300
confocal microscope, with a Plan Apo 60/1.4 nicotinic acid oil immersion
objective. Excitation of Cy5, OG 488, and Hoechst 33258 was performed using
637 nm red diode, 488 nm argon ion, and 405 nm blue diode lasers, and
emitted light was detected through HQ660 longpass and HQ515/30 and
HQ442/45 bandpass filters, respectively. Data were captured with BioRad
LaserSharp 2000 Software 5.1, and photographs were processed using Adobe
Photoshop software. Cells without DAF-2DA treatment or fixed cells (1 h with
4% paraformaldehyde), incubated with DAF-2DA, were used as negative
controls.
L-[3H] citrulline formation
Total NOS activity (in the presence of 1 mM calcium) and calcium-indepen-
dent activity (in the absence of calcium and in the presence of 1 mM EGTA)
were estimated [4] in PMNs (1107cells) CF and NF, incubated in buffer
[composition (mM): HEPES 25, NaCl 140, KCl 5.4, MgCl2 1, CaCl2 1, 7 g/ml
pepstatin A, 1.5 g/ml soybean trypsin inhibitor, 5 g/ml leupeptin, phenyl-
methylsulfonyl fluoride (PMSF) 0.5 mM, and benzamidine 0.1 mM, pH 7.4]
with cofactors [flavin adenine dinucleotide (FAD) 5 M, flavin monouncleotide
(FMN) 25 M, reduced nicotinamide adenine dinucleotide phosphate
(NADPH) 1 mM, BH4 10 M, and 10 g/ml CaM], and the L-[
3H] arginine
(0.16 M) at 37°C. The reaction was terminated after 30 min by stop buffer
[composition (mM): NaCl 118, KCl 4.7, KH2PO4 1.18, NaHCO3 1, EDTA 4,
N	-nitro-L-arginine methyl ester 1, pH 5.5] and was passed through a Dowex
50W-X8 column (100–200 mesh, Na
 form). L-[3H] Citrulline was collected
in the unbound wash fraction, and bound L-[3H] arginine was eluted with 0.5
M ammonium hydroxide to obtain citrulline formed from total arginine added
in each tube. To investigate the effect of CaM, NOS activity was estimated in
CF and NF in the presence of calcium and 10 or 100 g/ml CaM.
Flow cytometry
PMNs (2106cells/ml) or nuclei were incubated for 30 min with L-arginine (1
mM), 7-NI (1 mM), or vehicle at 37°C and subsequently, loaded with DAF-
2DA (10 M) for 30 min [7]. NO generation was measured by acquiring 10,000
cells/nuclei from each sample and was analyzed by the Cell Quest program.
Assessment of NOS expression
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA from PMNs and brain samples was extracted using Trizol reagent
(Invitrogen, Carlsbad, CA). RNA (5 g) was reverse-transcribed with Super-
Script II RT (Invitrogen) using oligo(dT) primers, as per the manufacturer’s
instructions. The cDNA was amplified in separate PCRs for NOS isoforms. The
PCR products were analyzed by electrophoresis on a 1.2% agarose gel and
visualized with ethidium bromide staining. The primers designed with a
Primer Select module of Lasergene (DNAStar Inc., Madison, WI) for nNOS
(5-AACGATCGGCCCTTGGTAGAC-3; 5-GGGCGGAGCTTTGTGCGAT-
TTG-3) amplified a 543-base pair (bp) fragment, iNOS (5-GGACCACCTC-
TATCAGGAA-3; 5-CCTCATGATAACGTTTCTGGC-3) amplified a 314-bp
fragment, and eNOS (5-TGCTGCCCGAGATATCTTCAGT-3; 5-GGCTGC-
CTTTTTCCAGTTGTTC-3) amplified a 356-bp fragment. The amplification
reactions for 30 cycles were denaturation, 94°C, 30 s; annealing, 49°C, 60°C,
and 65°C, 1 min for nNOS, iNOS, and eNOS, respectively; and extension,
72°C, 1 min. RNA from normal and LPS-treated rat brain samples was used as
positive controls.
Western blotting (WB) and immunoprecipitation (IP)
PMNs lysate [composition of lysis buffer (mM): NaCl 100, Tris-HCl 10, EDTA
1, 1 g/ml aprotinin, 100 g/ml PMSF, 20 g/ml pepstatin, and sodium
orthovanadate 2 mM, pH 7.4], protein was loaded on 15% (for caveolin-1) or
8% (for NOS) sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred onto a polyvinylidene difluoride membrane. Blocking
was done overnight [PBS; composition (mM): NaCl 137, KCl 27, Na2HPO4 32,
K2HPO4 15, KH2PO4 15, pH 7.4, containing 5% (w/v) BSA], and antibody
incubation was for 3 h with polyclonal caveolin-1 and NOS antibodies [1:1000
diluted in PBS containing 0.1% (v/v) Tween-20 and 1% (w/v) BSA]. The
specific bands were detected by enhanced chemiluminescence (Sigma-Aldrich
Co.), and blots were exposed to the Hyperfilms (Amersham Pharmacia Bio-
tech).
The cells were lysed in radio IP assay buffer [PBS containing 0.1% SDS,
0.5% sodium deoxycholate, 1% Triton X-100, and protease inhibitors (as in
lysis buffer)] for 15 min. The supernatant was precleared with protein A/G
agarose (Santa Cruz Biotechnology) and incubated with 0.2 g primary anti-
body; after 2 h, 20 l protein A/G agarose was added and incubated for 1 h.
The beads were washed, resuspended, and subsequently analyzed by WB. The
same concentration of normal immunoglobulin G (IgG) was used in controls for
WB and IP.
Confocal microscopy
Subcellular distribution of nNOS, iNOS, and caveolin-1 was examined in fixed
PMNs. The cells were fixed in 4% (w/v) paraformaldehyde in PBS (pH 7.4) for
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30 min at 25°C and washed two times for 5 min each with PBS containing 0.5%
(w/v) glycine. The washed cells were allowed to adhere on 0.01% (w/v)
poly-L-lysine-coated coverslips, permeabilized with 0.2% (v/v) Triton X-100
(5–10 min), and blocked with 10% goat serum in PBS for 30 min. Cells were
incubated overnight at 4°C with mAb against iNOS/nNOS and polyclonal
antibodies against caveolin-1 at a dilution of 1:200 and were subsequently
stained at 4°C for 4 h with Cy5 and OG 488-tagged secondary antibodies
(1:500), respectively. Nuclei were stained with Hoechst 33258 dye (3 g/ml)
at 25°C for 15 min. Control samples were processed separately by incubating
with normal rabbit, mouse, and goat sera or by omitting primary antibodies.
Coverslips were mounted in the fluorescence-mounting media (Oncogene, San
Diego, CA), and images were acquired as mentioned above. Red, green, and
blue images were collected separately with excitations at 647 nm, 488 nm, and
405 nm, respectively, to avoid bleed-through and merged for presentation
(Adobe Photoshop software, San Jose, CA).
Immunogold electron microscopy
Buffy coat (obtained by centrifugation of blood at 2000 rpm for 20 min at 25°C)
was fixed overnight with 2% (w/v) paraformaldehyde and 0.5% (v/v) glutaral-
dehyde in PBS (pH 7.4) at 25°C. Small pieces of buffy coat were washed with
PBS containing 0.5% (w/v) glycine to quench excess fixative, dehydrated in an
ascending series of ethanol, impregnated in London resin-White resin, and
subsequently polymerized at 60°C for 48 h. Ultrathin sections (80–100 nm)
collected on nickel grids [32] were blocked in PBS containing 0.1% BSA (w/v),
0.1% (v/v) teleost fish gelatin, and 0.05% (v/v) Tween-20 for 30 min and
incubated with nNOS or iNOS mAb at 1:500 dilution in blocking buffer for 4 h
at 4°C, and subsequently, the sections were incubated with 5/10/15 nm
gold-coupled goat anti-mouse IgG (1:20) for 2 h at 37°C and examined under
TEM at 80 kV.
In the dual-labeling experiments, ultrathin sections were incubated with
polyclonal caveolin-1 antibody (1:500) for 4 h at 4°C and subsequently, with
10 nm gold-coupled goat anti-rabbit IgG (1:20) and then treated with 0.01%
glutaraldehyde for 5 min to avoid leaching of gold particles. The excess
glutaraldehyde was quenched with 0.5% (w/v) glycine, and sections were
incubated with nNOS or iNOS antibodies (1:500) as described above. Sections
were washed with blocking buffer and treated with 15 nm gold-coupled
anti-mouse IgG antibody (1:20) for 2 h at 37°C. The dual-labeled sections were
contrasted with uranyl acetate and examined under TEM. Control samples
were processed separately by incubating with normal rabbit and mouse sera or
by omitting primary immunoprobes.
Morphometric analysis was done in images captured at magnification
11,000 from six grids of three independent experiments for nNOS or iNOS in
cytoplasm and nucleus [33]. Two gold particles positioned adjacent to each
other were also scored.
Statistical analysis
Results are mean  SEM of at least three to five independent experiments.
Comparisons between two groups were performed by unpaired t-test with
significance at P  0.05.
RESULTS
NO generation, NOS activity, and NOS molecular
characteristics evaluation in rat PMNs
NO formation assessment by DAF fluorescence
NO production in the subcellular compartments of PMNs was
visualized under a confocal microscope by using DAF-2DA.
Fluorescence of DAF was prominently seen in the granules,
cytoplasm, and perinuclear region (Fig. 1B). It is interesting
that it was also evident in the nuclear lobes (Fig. 1B). NO
generation in the nucleus suggests a possibility of functional
NOS enzyme in the nucleus of PMNs. Arrowheads in Figure 1B
indicate the regions of cytoplasm and nucleus with marked
DAF fluorescence.
Paraformaldehyde fixation of cells prior to the addition of
DAF-2DA blocked NO signal. The enzymatic production of NO
was also confirmed by the use of NOS inhibitor 7-NI or NOS
substrate L-arginine, which were decreased substantially (Fig.
1C) or increased (not shown), respectively. Fluorescent images
of DAF-2DA-loaded cells were collected over a period of 5–30
min, the punctate pattern of fluorescence seen in the granules,
and nuclear membrane was diffused completely within 20–30
min (Fig. 1D).
Conversion of L-[3H] arginine to L-[3H] citrulline
Direct evidence for the presence of NOS in the NF was ob-
tained by measuring the enzyme activity using L-[3H] arginine.
Purity of NFs was ascertained by estimating DNA content and
LDH activity. NF exhibited enrichment of DNA content (94%)
and negligible LDH activity, and 94% of total LDH activity
was found in the CF with DNA below the measurable limit.
Purity of the NF was also assessed by electron microscopy, and
electron micrographs of a typical PMN have been shown in
Figure 2Ai. Isolated nuclei of the PMNs are clearly visible
with negligible contamination of the cytoplasmic contents (Fig.
2Aii).
Calcium-dependent NOS activity was found only in the CF,
and it could not be detected in the NF using defined experi-
mental conditions. Calcium-independent (1 mM EGTA without
CaCl2) activity was, however, measurable in nuclear and CFs
(Fig. 2C).
NO measurement by flow cytometry
NO generation by DAF-2DA was also measured by flow cy-
tometry in the PMNs and isolated nuclei in the presence of
L-arginine (1 mM, NOS substrate) or 7-NI (1 mM, NOS inhib-
itor). NO formation was augmented in the presence of L-
arginine (Fig. 2Bi), and pretreatment of cells with 7-NI signif-
Fig. 1. DAF fluorescence indicating NO production in subcellular compart-
ments of PMNs. (A) Phase micrograph. (B) DAF fluorescence in the same cell
(A). Arrowheads demonstrate fluorescence in the nucleus, cytoplasm, and
perinuclear region (arrow). (C) DAF fluorescence in 7-NI (1 mM)-pretreated
cells. (D) Punctate pattern of fluorescence in the granules and perinuclear
region was diffused completely within 20–30 min. The displayed images are
representative of five independent experiments. Original bars represent 5 m
(A–D).
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icantly reduced NO generation. Similar assay in the NF of
PMNs also demonstrated an increase in NO synthesis in the
presence of NOS substrate, L-arginine, and attenuation in the
presence of NOS inhibitor 7-NI (Fig. 2Bii). It confirmed NOS-
dependent NO synthesis in the NF.
Molecular characterization of NOS
To identify NOS isoforms in the PMNs, RT-PCR experiments
were conducted by isolating RNA. The presence of nNOS and
iNOS was evident (Fig. 3B), and signal for eNOS was not
detected in the rat PMNs (Fig. 3D). Absence of eNOS (Fig. 3D)
and presence of nNOS in PMNs were confirmed by using rat
brain as a positive control, and for iNOS, LPS-treated brain was
used as a positive control. WB experiments further confirmed
the presence of these isoforms in the PMN lysate (Fig. 3, A and
C). Level of nNOS expression in PMNs was low in comparison
with the cerebellum. Primers used for nNOS detection indi-
cated the presence of the PDZ domain in NOS, which was
further substantiated by WB using N-terminal nNOS antibody
(K-20: sc-1025).
NOS subcellular localization by
immunocytochemistry
Electron microscopy
Exploration of NOS localization by immunoelectron micros-
copy revealed the presence of nNOS and iNOS in various
subcellular compartments in the PMNs. Experiments con-
ducted with mAb as well as polyclonal antibodies (data not
shown) exhibited specific labeling and indicated the presence
Fig. 2. Purity assessment, NO generation, and NOS activity in CF and
NF fractions of PMNs. (A) Electron micrographs of (i) neutrophil/(ii) NF.
Original bars represent 1.4m (i) and 1 m (ii). N, Nucleus; PG, primary
granules. (B) Flow cytometry experiment demonstrating NO generation
from (i) PMNs and (ii) isolated nuclei. NO generation in (i) PMNs: a,
without DAF; b, with DAF; c, L-arginine (1 mM); and d, 7-NI (1 mM)
treatment. (ii) Nuclei were gated by using 7-aminoactinomycin D staining:
a, without DAF; b, loaded with DAF-2DA; c, L-arginine (1 mM); and, d
7-NI (1 mM). Nuclei suspension also contained cofactors (FAD, FMN,
NADPH, BH4, and CaM). The histograms are representative of five
independent experiments. (C) Ca2
-dependent and -independent NOS
activities in the CF and NF. Values are mean  SEM of at least five
experiments. *, P  0.01, in comparison with calcium-independent
activity.
Fig. 3. Molecular characteristics of NOS in rat
PMNs. WB of (A) nNOS: lane 1, rat cerebellum (20
g); lane 2, PMNs (60 g); (C) iNOS: lane 1, 60 g;
lane 2, 100 g PMN lysate; and (G) caveolin-1:
lane 1, PMN lysate (60 g); lane 2, fibroblast L929
(60 g). (B) RT-PCR products of NOS isozymes in
rat PMNs. Lane 1, Molecular weight marker; lane 2,
nNOS (20 l); lane 3, iNOS (10 l). (D) RT-PCR
product of eNOS. Lane 1, Molecular weight marker;
lane 2, eNOS in rat brain; lane 3, eNOS in rat
PMNs. (E) Lane 1, nNOS (20 l); (F) iNOS (20 l)
in caveolin-1 IP from PMN lysate.
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of nNOS as well as iNOS isoforms at various locations. No
appreciable binding was seen in the case of labeling only with
secondary antibody with variable sizes of gold particles (10 and
15 nm). Evaluation with 5 nm gold particles was, however,
obscure or difficult to differentiate from electron-dense gran-
ules scattered in the cytoplasm and heterochromatin region of
nuclear lobes. Experiments were therefore conducted with 10
and 15 nm gold particles; it was found that immunolabeling
with 15 nm gold particles was distinct and more convenient for
morphometric analysis.
iNOS and nNOS staining was clearly seen in the nuclear
membrane, nucleus (Figs. 4, B and C, and 5D) and nuclear
pore. iNOS/nNOS immunostaining was quite prominent along
the plasma membrane (Figs. 4B and 5C) and in primary
granules (Figs. 4D and 5E). The higher magnification clearly
showed gold particles corresponding to iNOS in the phagocytic
cup (Fig. 4E), cytosol, and mitochondria (Fig. 4F). Compari-
sons between nNOS and iNOS immunolabeling patterns re-
vealed that nNOS was mostly localized in the cytoplasm, and
nNOS immunoreactivity in the nucleus was significantly less
than iNOS. Negligible background labeling with no apparent
staining in the primary granules, cytoplasm, and nucleus was
observed in the controls (Figs. 4A and 5A).
NOS immunolabeling was quite evident as dimers (Figs. 4B
and 5B), and in many fields, it was in monomeric form. We
counted the gold particles to represent nNOS and iNOS dis-
tribution in 15 and 16 representative cells, respectively. Total
number of gold particles to represent iNOS distribution in
PMNs was 86  5 (n16), which was significantly more than
nNOS (392, n15, P0.001). Among the isoforms, distri-
bution of nNOS was, however, different than iNOS. nNOS was
much more in the cytoplasmic compartments (almost 70%),
and more than 50% iNOS was localized in the nuclear com-
partment. Moreover, distribution of iNOS (41/cell) and nNOS
(52/cell) was similar in the azurophilic granules, and asso-
ciation of nNOS (151/cell) with the plasma membrane was
significantly higher than iNOS (82/cell, P0.005).
Confocal microscopy
The presence of iNOS and nNOS in nuclear lobes of PMNs was
further assessed by immunofluorescent microscopy, which vi-
sualized many cells to provide more information in the same
experiment. iNOS and nNOS showed plasmalemmal, cytoplas-
mic, as well as nuclear distribution. Three main sites could be
visualized clearly in these acquisitions. First, most of the cells
showed diffused intracytoplasmic staining, although nNOS
staining intensity showed less variability, but iNOS staining
differed in intensity from cell to cell. Second, we found staining
in a discrete intracellular punctate pattern (Fig. 6, Aii and
Bii), consistent with a granular/vacuolar localization of NOS.
Third, staining was clearly visible in the nuclear lobes but was
less than the cytoplasm (Fig. 6, Aii and Bii), which could be a
result of the less approachability of antibody in the nuclear
lobes, as binding was done in permeabilized cells, unlike
sections being used for electron microscopy. To determine
whether nNOS and iNOS were localized within the nucleus, we
stained nucleus as well as cells with NOS antibodies. Figure 6,
Aii and Bii, provided convincing evidence of nNOS (red) and
iNOS (red) in the nuclear lobes (as shown by arrowheads) of
PMNs. Preimmunized, serum-related immunoreactivity was not
detected in negative control samples (Fig. 6, Av and Bv).
IP and identification of NOS-interacting protein
As nNOS and iNOS interact with several proteins in various
cells, we explored the possibility of NOS interaction with
caveolin-1, an important NOS-interacting protein. We used
caveolin-1 antibody for IP; following SDS-PAGE, the blots
were probed with nNOS or iNOS antibody. The presence of
both NOS isoforms was seen (Fig. 3, E and F), thus suggesting
interaction of nNOS and iNOS with caveolin-1. The presence of
caveolin-1 in PMN lysate was also evident by WB (Fig. 3G).
Fig. 4. Localization of NOS in PMNs by immunoelectron microscopy. The
presence of iNOS (15 nm) in the nucleus, PG (azurophilic), plasma membrane,
nuclear membrane, and cytosol is shown. (A) Immunoreactivity with preim-
munized sera was not detected in the control samples. (B) iNOS staining as
monomers and dimers (arrows). (C) iNOS in nucleus, (D) in PG, (E) in
phagocytic cup (5 nm gold particles), and (F) in mitochondria. Original brs
represent 100 mm (A), 0.5 m (B), 200 nm (C), 20 mm (D), 2 m (E), and 40
nm (F).
Fig. 5. Distribution of nNOS in the rat PMNs. nNOS is prominently observed
in cytoplasm, plasma membrane, nucleus, and nuclear membrane, along the
plasma membrane and in primary granules. nNOS staining in (A) negative
control treated only with gold-labeled, secondary antibody; (B) cytoplasm,
plasma membrane, nucleus, and nuclear membrane; (C) along the plasma
membrane; (D) nucleus and nuclear membrane; and (E) primary granuels.
Original bars represent 500 nm (A), 1 m (B), and 200 nm (C–E).
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NOS and caveolin-1 colocalization studies
To investigate iNOS and nNOS colocalization with caveolin-1
in the PMNs, we used immunoelectron microscopy as well as
confocal immunofluorescence microscopy. Colocalization of
iNOS and nNOS with caveolin-1 was performed by using 15 nm
gold-conjugated secondary antibodies to immunolabel iNOS or
nNOS and 10 nm gold-conjugated secondary antibodies to
label caveolin-1, which was mostly found as oligomers (Fig. 7,
A and B) as clusters of two to four gold particles corresponding
to caveolin-1, which were occasionally present adjacent to the
plasma membrane, nuclear membrane, nucleus, and cyto-
plasm. iNOS (15 nm gold particle) colocalization with caveo-
lin-1 (10 nm gold particles) is seen in the cytoplasm (Fig. 7D)
and inside the nucleus (Fig. 7C). As nNOS immunostaining
was always less as compared with iNOS, areas of colocalization
of nNOS with caveolin-1 were also relatively less in the cyto-
plasmic and nuclear compartments. Single labeling was also
done simultaneously with double-labeling experiments for
caveolin-1 and NOS by using 10 and 15 nm, respectively, to
ascertain any artifactually cross-labeling.
To further corroborate these findings, iNOS/nNOS colocal-
ization with caveolin-1 was also evaluated by confocal micros-
copy. In these experiments, OG 488-labeled secondary anti-
body was used, as density of NOS or caveolin-1 was not high in
these cells. No fluorescence was observed when the cells were
incubated alone with the secondary antibody. Caveolin-1 an-
tibody binding was quite marked as was immunofluorescence
labeling of iNOS (Fig. 6Aii) or nNOS (Fig. 6Bii). NOS and
caveolin-1 exhibited subcellular distribution in cytoplasm as
well as in the nucleus. A punctate pattern of fluorescence was
seen in the plasmalemma and cytoplasm with relatively less
staining of NOS and caveolin-1 in the nucleus (Fig. 6, A and
B). Nuclear distribution of caveolin-1 was more in comparison
with NOS isoforms (Fig. 6, Aiii and Biii). Areas of colocaliza-
tion (Fig. 6, Aiv and Biv) of the two proteins are clearly evident
as yellow in the merged images.
CaM-mediated modulation of NOS activity
NOS activity in the PMN lysates NF and CF was estimated in
the absence and presence of CaM (10 and 100 g/ml; Fig. 6C).
With a tenfold increase in CaM concentration, NOS activity
was augmented significantly in the nuclear (117%) as well as in
the CFs (140%; Fig. 6C), indicating possible activity modula-
tion of NOS by caveolin-1 and CaM in the PMNs.
DISCUSSION
Intracellular messengers, including pleiotrophic molecule NO,
modulate diverse signaling cascades in the various subcellular
Fig. 6. Colocalization of NOS isoforms with caveo-
lin-1 and CaM-mediated modulation of NOS activity
in CF and NF of PMNs. (A) iNOS immunolabeling
(i), nucleus (blue; ii), iNOS (red; iii), caveolin-1
(green; iv), merge of ii and iii (v) negative control
incubated with preimmunized sera. (B) nNOS immu-
nolabeling (i), nucleus (blue; ii), nNOS (red; iii),
caveolin-1 (green; iv), merge of ii and iii (v) negative
control for caveolin-1 with preimmunized sera. Ar-
rowheads indicate the nuclear regions with clearly
visible iNOS or nNOS staining. Arrows in merged
images indicate colocalization (yellow) of NOS with
caveolin-1 in nucleus. Original bars represent 5 m
(A, B). (C) Histogram representing NOS enzyme
activity in CF and NF of PMNs. Addition of CaM
(100 g/ml) significantly augmented NOS activity.
Values are mean SEM of three independent exper-
iments. *, P  0.05; **, P  0.01, in comparison
with the absence of Ca2
 and CaM; and #, P 0.05,
in comparison with the presence of CaM (10 g/ml).
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compartments to regulate PMN functions such as adhesion,
chemotaxis, phagocytosis, respiratory burst, and apoptosis.
NOS inhibition augmented the number of neutrophils in the
mouse bone marrow and blood, suggesting a regulatory role of
NO, even in hematopoiesis [34]. Specific functions of NO in
neurons, skeletal muscles, and endothelial cells have been
attributed to NOS localization in a particular compartment,
despite that NO can easily reach to distant targets by diffusion
[25, 35, 36]. Such compartmentalized distribution of NOS has
not yet been explored in the PMNs. The present study aims to
investigate intracellular NOS expression in rat-circulating
PMNs by using a combination of biochemical, molecular, con-
focal, and immunoelectron microscopy techniques.
The N-nitrosation of DAF, a NO detection dye yielding a
highly green fluorescent triazole form (DAF-2T), offers not only
the advantages of specificity, sensitivity, and a simple protocol
for the direct NO detection but also sufficient resolution to
locate NO in the subcellular compartments. The observations
recorded within 5–10 min after DAF addition exhibited NO
formation in the granules, perinuclear region, cytosol, and
nuclear lobes (Fig. 1B), which was significantly reduced in the
presence of NOS inhibitor 7-NI (Fig. 1C). Fluorescent images
collected after 20–30 min did not show the punctate pattern of
fluorescence in the granules and nuclear membrane, rather a
completely diffused pattern was seen (Fig. 1D). In view of the
NO diffusibility [37], a part of fluorescence in the nucleus
could be a result of its dispersion from cytoplasmic compart-
ments. Experiments with DAF were suggestive of NO formation
in the subcellular compartments and prompted us to undertake
systematic evaluation of NOS localization in the PMNs.
Prior to the NOS distribution studies, molecular character-
istics of NOS were verified by RT-PCR using isoform-specific
primers. The presence of nNOS and iNOS mRNA in the PMNs
was seen (Fig. 3B), and eNOS mRNA could not be detected
(Fig. 3D). nNOS and iNOS expression was further confirmed by
WB (Fig. 3, A and C). Only one report was found in literature
about the characterization of NOS isoforms in rat PMNs [14].
The level of nNOS expression in PMNs was low in comparison
with the cerebellum, which is in agreement with our finding
[14]. Constitutive expression of iNOS in the present study was,
though, surprising, as iNOS induction was observed by Green-
berg et al. [14] within 2 h after LPS treatment or bacterial
infections, with no adverse effect on the nNOS expression. We
had also observed a significant increase in NOS activity in
PMNs after LPS treatment in rats [5]. Ambient bacterial load
could be responsible for the constitutive presence of iNOS in
the present study. Controversy in the expression of NOS iso-
forms in rat brain has also been documented [38]. A systematic
study conducted by Keilhoff et al. [38] demonstrated detect-
able mRNA for iNOS and nNOS in rat brain during embryonic
development on Day 10, and proteins were detected only at
Day 15; others, however, failed to observe a constitutive pres-
ence of iNOS in rat brain. Human PMNs, which exhibit similar
functional responses to the addition of NO donors [1], however,
constitutively express nNOS and iNOS [14, 39]. Constitutive
presence of iNOS has been documented in some cells and is
not considered to be the only inducible activity [40]. PMNs, an
important part of innate immunity, offer protection against
microbes due to generation of reactive oxygen and nitrogen
species. Constitutive expression of iNOS in PMNs is to support
NO synthesis in large amounts, and macrophages express iNOS
only after exposure to LPS [40].
Based on WB and RT-PCR experiments (Fig. 3, A and B),
nNOS in rat PMNs seems to be a full-length PDZ domain-
containing protein [15]. PDZ domains are protein-interaction
domains, which play an important role in the targeting of
proteins to specific membrane compartments and their assem-
bly into supramolecular complexes. PDZ domains, though,
share a common, three-dimensional structure but generally,
differ in their binding specificities. PDZ proteins mostly inter-
act with target proteins without disrupting the overall structure
and ligand function as a result of their ability to bind short,
extreme C-terminal sequences [41–43]. PDZ domain interac-
tion with the carboxyterminal tail is critical for PSD-95, K

channels, and the N-methyl-D-aspartate receptor clustering,
suggesting the physiological relevance of proper subcellular
localization of these proteins [23]. PDZ domain of syntrophin
mediates association of nNOS with the dystrophin complex in
the skeletal muscles [35]. Receptor tyrosine phosphatase-
like protein, phosphofructokinase, calcium/CaM-dependent
ATPase, and carboxy-terminal-binding protein [41, 42, 44] are
also some important PDZ-interacting proteins. The last two
proteins have a strong presence in the nuclear compartment
and regulate transcription. As nNOS in PMNs also possess a
PDZ domain, it is likely to interact with PDZ domain-interact-
ing proteins in PMNs to regulate some important functions. The
Fig. 7. Colocalization of NOS with caveolin-1 in rat PMNs. (A) Caveolin-1 (10
nm) localization in rat PMNs by immunoelectron microscopy. Arrows indicate
clearly visible caveolin-1 immunolabeling. (B) Caveolin-1 immunolabeling
(oligomers) prominently seen in the nucleus, nuclear membrane (NM), and
plasma membrane (PM). (C) Colocalization of iNOS (15 nm) with caveolin-1
(10 nm) in the nucleus and (D) cytoplasm. Areas of colocalization shown are
magnified in insets. Original bars represent 100 nm (A) and 100 mm (B–D).
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results obtained thus warrant further investigations to identify
the NOS-interacting proteins in PMNs.
Distribution of nNOS and iNOS proteins was subsequently
explored in the fixed PMNs by confocal and immunoelectron
microscopy. Differences in the expression of nNOS and iNOS
with distinct overlapping in their distribution in various intra-
cellular compartments [azurophilic granules (Figs. 4D and 5E),
mitochondria (Fig. 4F), endoplasmic reticulum (not shown),
and phagocytic vacuoles (Fig. 4E)] and their prominent pres-
ence in nucleus were evidenced (Figs. 4–6). NOS colocaliza-
tion was documented with myeloperoxidase within primary
granules [2], which was also apparent in the present study
(Figs. 4D and 5E). The presence of NOS in various subcellular
compartments such as mitochondria [45], cardiac sarcoplasmic
reticulum [46], insulin secretary granules [47], and mast cell
granules [48] has been documented. Moreover, the presence of
NOS isoforms in the nucleus of the cultured neonatal cardio-
myocytes [46], pancreatic -cells [47], brown adipocytes [10],
mast cells [48], and astrocytes [11] has also been reported.
NOS distribution in the subcellular compartments might be to
restrict NO signaling to specific sites to perform explicit func-
tions. To delineate the significance of nuclear NOS in PMNs,
its role/trafficking in the myeloid cell lineage with particular
emphasis on neutrophil maturation should be investigated.
Moreover, studies about NOS in the nuclear compartment
demonstrated distinct patterns. In the cultured astrocytes,
nNOS translocation to the nucleus on seventh day lasted for
only 10 h, which was speculated to down-regulate iNOS tran-
scription [11]. Augmentation in the intracellular calcium level
during mast cell activation further enhanced eNOS transloca-
tion to the nucleus, but nNOS distribution remained unaltered
[48]. All the studies conducted so far have remained specula-
tive to define the role of nuclear NOS [10, 11, 46–48]. Besides,
nuclear localization of CaM [49] and BH4 biosynthetic enzymes
[12] are of significant relevance to the presence of NOS in this
compartment. S-Nitrosylated glyceraldehyde 3-phosphate de-
hydrogenase has been found to initiate apoptotic cell death in
neurons, indicating that S-nitrosylation is a ubiquitous, post-
translational modification to regulate protein functions and
their translocation [50]. NO-mediated S-nitrosylation, ubiquiti-
nation, oxidation, protein phosphorylation, activation of phos-
phatases, or altered protein interactions might activate or in-
hibit transcription by modulating transcription factors and
signaling cascade [51, 52]. Even initiation of the transcription
process by RNA polymerase I and II in conjunction with actin
and myosin I [53] seems to be modulated by cyclic guanosine
3,5-monophosphate-dependent protein kinase by dephospho-
rylating myosin light chain [54], which further signifies the
presence of intranuclear NOS. Studies are, however, required
to define the exact role of NOS/NO in the nuclear compartment.
Morphometric analysis of the cells after immunoelectron
microscopy revealed that PMNs have more iNOS in comparison
with nNOS, which is in agreement with the biochemical as-
sessment of NOS activity (Figs. 1 and 2C). iNOS immunore-
activity was almost equally distributed in the nucleus and
cytoplasm. Although 70% of the total nNOS resided in the
cytoplasm (subcellular organelles excluding nucleus), only
30% was localized in the nucleus. Calcium-independent ac-
tivity, which is possibly a result of iNOS, was found in NF and
CF (Fig. 2C), exhibiting good correlation with the morphomet-
ric analysis. Although the presence of nNOS was evident in the
nucleus by immunolabeling (Figs. 5B and 6Bii), calcium-
dependent NOS activity was detected only in the cytoplasm
and could not be measured under the experimental conditions
used in the NF (Fig. 2C). Kinetic parameters for NO synthesis,
such as oxygen affinity and dissociation constant to release NO
from heme, are distinctly different for nNOS and iNOS [55].
nNOS is likely to synthesize NO as well as nitrate, and iNOS
can sustain NO formation even during hypoxic conditions. As
nNOS binding and calcium-dependent NOS activity are mostly
enriched in the cytoplasm, its metabolite nitrite and nitrate are
likely to be used more effectively in combination with myelo-
peroxidase and hypochlorous acid to generate toxic nitrogen
species, nitryl chloride, and nitrogen dioxide [5, 56, 57]. iNOS,
which generate NO, even at low oxygen tension, might have
important implications in inflammatory conditions and cell
survival. Although unprecedented, based on existing results, it
can be extrapolated that NOS might even perform functions
other than NO synthesis, such as protein activity modulation by
physical interactions, and their localization in the specific
cellular compartment may not necessarily require enzymati-
cally active NOS.
A tenfold increase in CaM concentration augmented NOS
activity substantially and significantly in both of the compart-
ments (Fig. 6C). CaM, in high concentrations, displaces bind-
ing of NOS with negative regulatory proteins, such as caveo-
lin-1 [24]. Moreover, inhibitory influence of the autoinhibitory
loop at a FMN-binding site in nNOS is also removed by the
excess CaM [58–60]. Although the presence of caveolin-1 in
human PMNs is controversial [61, 62], no such report is
available about rat PMNs. The present study thus explored the
presence of caveolin-1 in the rat PMNs, which down-regulates
activity of all three NOS isoforms [25, 26, 63, 64]. Caveolin-1
antibody (Santa Cruz Biotechnolgoy, N-20: sc-894), used by us
to demonstrate the presence of the caveolin-1  isoform (full-
length caveolin), has been used frequently by other investiga-
tors [64, 65]. Caveolin-1 and its oligomers in rat PMNs were
seen by electron microscopy (Fig. 7, A and B) and subse-
quently confirmed by WB and IP (Fig. 3, E–G). Caveolin-1 IP
was positive for nNOS (Fig. 3E) and iNOS (Fig. 3F) when
probed with NOS antibodies, indicating their interaction in the
rat PMNs. Confocal and electron microscopy also confirmed
colocalization of nNOS and iNOS with caveolin-1 (Figs. 6, Aiv
and Biv, and 7, C and D). Caveolin-1, apart from keeping the
enzyme inhibited in the resting cells, can also help in the
trafficking of NOS to different subcellular compartments [9, 66,
67]. Use of caveolin-1 peptides might thus help to delineate
mechanisms involved in CaM-induced activation of NOS and
identify the specific amino acids responsible for the observed
interaction.
The results obtained indicate a constitutive presence of
iNOS, nNOS, and caveolin-1 in the subcellular compartments
of rat PMNs including nucleus. NOS seems to interact with
caveolin-1 in PMNs and remains inhibited. The present study
demonstrates for the first time functionally active NOS isoforms
in the nuclear and intracellular compartments, adding a new
approach to ascertain the significance of NO in diverse func-
tions of PMNs. As the initial product of NOS enzymatic catal-
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ysis is a ferric heme-NO complex and not free NO [55],
localization of NOS in subcellular compartments of rat PMNs
may serve a definitive role in the compartmentalized redox
signaling.
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